ArticleUrolithiasis2026
Computed Tomography-Derived visceral fat area is associated with increased risk of kidney stone recurrence.
Article in Urolithiasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Visceral adiposity has been implicated in metabolic dysregulation and chronic inflammation, both of which may contribute to kidney stone recurrence. However, accurate and reproducible quantification of visceral fat in routine clinical practice remains challenging. This study aimed to investigate the association between visceral fat area (VFA) quantified from computed tomography (CT) images and the risk of kidney stone recurrence. We retrospectively analyzed patients with urolithiasis who underwent abdominal CT imaging. Visceral fat area was automatically quantified using a previously validated artificial intelligence (AI)-based CT segmentation system. Clinical characteristics and stone recurrence outcomes were collected. Multivariable regression models were applied to assess the association between VFA and stone recurrence after adjustment for relevant confounders. A total of 131 patients were included, of whom 73 (48%) experienced stone recurrence during a mean follow-up of 47 weeks. Patients with recurrence had significantly higher visceral fat area. High VFA was independently associated with increased recurrence risk (adjusted hazard ratio [HR] 1.71, 95% confidence interval [CI] 1.03 to 2.82). Subgroup analyses demonstrated a stronger association in younger patients (HR 2.45, 95% CI 1.23 to 4.89), while no significant association was observed in older patients or across sexes. CT-derived visceral fat area was independently associated with kidney stone recurrence in this retrospective cohort. These findings suggest that visceral adiposity may serve as a useful imaging biomarker for risk stratification. Further prospective studies are warranted to validate its clinical utility.
Indexed as
Identifiers
42295440What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.